Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

OMEROS CORPORATION

(OMER)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about OMEROS CORPORATION
08/03OMEROS CORPORATION : to Announce Second Quarter Financial Results on August 9, 2..
BU
06/18OMEROS : WBB Securities Reinstates Omeros With Strong Buy, $100 Price Target
MT
06/16OMEROS : Form 8-K)
PU
06/15OMEROS' : Narsoplimab pivotal trial data shared in oral presentation at 2021 ann..
AQ
06/14OMEROS : rsquo; Narsoplimab Pivotal Trial Data Shared in Oral Presentation at 20..
BU
06/14Omeros Corporation Announces Narsoplimab Pivotal Trial Data in Oral Presentat..
CI
06/10OMEROS : Announces Publication Detailing the Mechanism of Action of PDE7 In Nico..
BU
06/09OMEROS : to Present at the BofA 2021 Napa BioPharma Virtual Conference
BU
06/09OMEROS : Says OMS906 Was Well-Tolerated in Phase 1 Trial in Alternative Pathway-..
MT
06/09OMEROS : Announces Preliminary Results from Phase 1 Clinical Trial of OMS906
BU
06/09Omeros Announces Preliminary Results from Phase 1 Clinical Trial of OMS906
CI
06/01SHAREHOLDER ALERT : Pomerantz Law Firm Investigates Claims On Behalf of Investor..
PR
05/31OMEROS : Announces preliminary results from additional critically ill covid-19 p..
AQ
05/28OMEROS : Unveils Initial Results From Narsoplimab Treatment of Additional 'Criti..
MT
05/28OMEROS : Announces Preliminary Results from Additional Critically Ill COVID-19 P..
BU
More most relevant news
All news about OMEROS CORPORATION
08/03OMEROS CORPORATION : to Announce Second Quarter Financial Results on August 9, 2..
BU
06/18OMEROS : WBB Securities Reinstates Omeros With Strong Buy, $100 Price Target
MT
06/16OMEROS : Form 8-K)
PU
06/16OMEROS CORP : Submission of Matters to a Vote of Security Holders, Financial Sta..
AQ
06/15OMEROS' : Narsoplimab pivotal trial data shared in oral presentation at 2021 ann..
AQ
06/14OMEROS : rsquo; Narsoplimab Pivotal Trial Data Shared in Oral Presentation at 20..
BU
06/14Omeros Corporation Announces Narsoplimab Pivotal Trial Data in Oral Presentat..
CI
06/10OMEROS : Announces Publication Detailing the Mechanism of Action of PDE7 In Nico..
BU
06/09OMEROS : to Present at the BofA 2021 Napa BioPharma Virtual Conference
BU
06/09OMEROS : Says OMS906 Was Well-Tolerated in Phase 1 Trial in Alternative Pathway-..
MT
More news
News in other languages on OMEROS CORPORATION
2019Principales informations avant-Bourse
2019Lonza coopère avec Omeros pour la commercialisation du Narsoplimab
More news
Analyst Recommendations on OMEROS CORPORATION
06/18OMEROS : WBB Securities Reinstates Omeros With Strong Buy, $100 Price Target
MT
04/26OMEROS : HC Wainwright Adjusts Omeros' Price Target to $32 From $34, Keeps Buy R..
MT
02/01OMEROS : UBS Starts Omeros at Buy With $25 Price Target
MT
01/20OMEROS : HC Wainwright Adjusts Omeros' Price Target to $34 from $31, Keeps Buy R..
MT
01/20OMEROS : Wedbush Adjusts Omeros' Price Target to $18 From $13, Maintains Neutral..
MT
More recommendations
Press releases
08/03OMEROS CORPORATION : to Announce Second Quarter Financial Results on August 9, 2..
BU
06/16OMEROS : Form 8-K)
PU
06/16OMEROS CORP : Submission of Matters to a Vote of Security Holders, Financial Sta..
AQ
06/15OMEROS' : Narsoplimab pivotal trial data shared in oral presentation at 2021 ann..
AQ
06/14OMEROS : rsquo; Narsoplimab Pivotal Trial Data Shared in Oral Presentation at 20..
BU
More press releases
Upcoming event on OMEROS CORPORATION
08/10/21